Analysts Issue Forecasts for AVBP Q2 Earnings
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) – Stock analysts at Lifesci Capital issued their Q2 2025 earnings per share (EPS) estimates for ArriVent BioPharma in a research note issued to investors on Monday, June 23rd. Lifesci Capital analyst S. Slutsky anticipates that the company will post earnings of ($0.75) per share for the quarter. […]
